Retatrutide FDA approval is attracting attention as researchers investigate new treatments for obesity and metabolic disorders. Developed by Eli Lilly and Company, retatrutide is an experimental medication designed to activate three hormone receptors involved in appetite regulation, blood glucose control, and energy […]